Your cart is currently empty!
FDA Approves New Pancreatic Cancer Drug After Trial Nearly Doubled Median Survival

A new treatment has been approved for one of the most difficult cancers to treat, and the clinical trial results behind the decision are already drawing major attention. The FDA has approved Rasonque, also known as daraxonrasib, for certain adults with advanced pancreatic cancer after a study found that patients taking the drug had a…
The Cancer With a 97% Death Rate Just Lost Its ‘Untreatable’ Status

Pancreatic cancer has earned a terrifying reputation as a disease that simply cannot be stopped. It moves fast, hides well, and has resisted almost every drug thrown its way. But the label of “untreatable” might finally be losing its grip. A groundbreaking study out of Spain has managed to do what was once thought impossible,…
Teen Researcher Challenges Decades Old Cancer Testing Norms After Personal Loss Sparks Breakthrough Idea

In an era when medical innovation is often associated with major research institutions and seasoned scientists, one of the more unexpected challenges to the status quo came from a high school student asking a deceptively simple question. Why was pancreatic cancer, a disease known for its severity, still so rarely detected in time to change…

